LifeVantage Corporation (NASDAQ: $LFVN) reported 3QFY26 results below expectations as continued declines in the MindBody GLP-1 customer cohort pressured active accounts and revenue growth. 🔹 Active accounts declined to 109k as competition from pharmaceutical GLP-1 alternatives continued to weigh on the MindBody customer base 🔹 Incoming CEO Terrence Moorehead joins in August, bringing more than 25 years of direct selling and consumer products leadership experience 🔹 Management highlighted the new VIP bonus program and an upcoming science-backed “hero product” launch as potential catalysts for renewed growth momentum Check out Douglas M. Lane, CFA's full report for more! $LFVN #HealthAndWellness# #Nutrigenomics# #ConsumerHealth# #Supplements# #DirectSelling# #NASDAQ# #SmallCap# #Stocks# #Investing# #Wellness# #WaterTowerResearch# @lifevantage

Life update: today is my last day at @insightpartners Hard to overstate what these years have meant to me. The gift Insight gave me is agency - the freedom to explore, build, and break things. I got to grow as an investor and build agentic systems at the same time, in the same place - that combination is rare. Feel lucky to be doing this work in a moment like this - a sci-fi era where computers can talk back, think with us, build with us. What a time! Matt, Max, Byron, Alessandro, Max, Hugues - thank you for betting on me, taking me under your wing, and shaping how I think. You are the firm. To the founders I've worked with: you are the most relentless, optimistic, brilliant people I know. Thank you for letting me into your stories. Building is a long game - I'm in it with you. Arrivederci, Insight!! What's next: more soon 🙌